Keyword prof amin karmali

back to newsletters

Displaying 1 - 5 of 5 newsletters tagged with this topic.

Download PDF

December'13

In this issue, Prof. Amin Karmali compares in vitro the impact of proteolytic enzymes on the beta-glucan content, enzyme content and secondary metabolite content between a biomass form of Ganoderma lucidum (Reishi) versus an extracted form of Ganoderma lucidum. Various forms of Beta 1,3 -1,6 glucan activities are measured, such as water soluble fraction, hot water fraction, NaOH fraction, KOH fraction and HCI fraction. In terms of enzymes, measurements, super-oxide dismutase activity (SOD), peroxidase activity, Glucoamylase/Beta-glucanasase activity, Glucose 2-oxdase activity, Cytochrome “P-450”, Cytochrome P 450 reductase were taken in the absence of proteolytic enzymes and in the presence of proteolytic enzymes.

A copy of Professor Todor Chernev´s poster presentation entitled “Coriolus-MRL supplementation in patients infected with low-risk and high-risk HPV subtypes - Bulgarian experience. The original poster presentation on the use of Coriolus-MRL in two separate studies (100 patients and 200 patients respectively) reinforces the original clinical work by Dr. Silva Couto in which Coriolus-MRL is a useful tool for gynecologists when working with HPV LSIL patients with High risk viral subtypes.

Presented is an English translation of a 2008 Bulgarian Medline article on Coriolus-MRL by Dr. Yuliyana Bogdanova (PhD) from the Bulgarian Institute of Botany, Bulgarian Academy of Sciences, in Sofia, Bulgaria. The study outlines the clinical development of Coriolus-MRL.

Finally, Professor Vittorio Calabrese (University of Catania, Italy) and Professor Tito Fernandes (Scientific Director, University of Lurio, Mozambique) propose to use mushroom nutrition in Alzheimer´s patients. This two-part proposal is focused on the premise that the HSV1 virus could trigger the biochemical events that lead to the development of Alzheimer´s disease. The paper relies on work conducted by researchers working with Dr. Frank M. LaFerla at the at the department of Neurobiology and Behavior at the university of California Irvine, in Irvine California and to work conducted by researchers working with Professor Ruth Itzhaki in the University of Manchester in the United Kingdom. As a first step, the proposed protocol seeks to verify that Coriolus-MRL when combined equally with Hericium-MRL can activate Lipoxin A4 (LXA4) activity which has been postulated as a novel approach to addressing the symptoms associated with Alzheimer´s disease. With confirmation that mushroom nutrition can activate LXA4 activity, then a small scale human study will be initiated.

read more
Download PDF

March'07


The Clinical Journal of Mycology (formerly Mycology News) is dedicated to the dissemination of information on the clinical use of mushroom nutrition to health care practitioners. In this issue we address the role of Coriolus versicolor in the treatment of CIN-1 (LSIL HPV) and Herpes Simplex.

Dr J Silva Couto outlines the difference between LSIL and HSIL HPV and provides a protocol for use by medical professionals. In addition, Prof Amin Karmali explains the enzymatic qualities of Coriolus versicolor and how such attributes assist the immune system. Finally, Dr. Andrew French outlines his clinical experience using Coriolus versicolor in patients with herpes simplex with a recommended protocol for consultants.

read more
Download PDF

September'05

In this edition, Dr Rajendra Sharma presents the results of 13 patient study on the use of Coriolus-MRL supplementation (4,5 g day over 90 days) in Leaky Gut Syndrome. Dr Jean Monro outlines a prospective trial design for HPV control with Coriolus versicolor. A prostate cancer case study is outlined in which the patient, Gary Bates, describes his experience taking Coriolus versicolor an Cordyceps sinensis supplementation while undergoing hormone blocking treatment. Dr Girao Bastos outlines the use of Coriolus supplementation in a dog with prostate cancer. The TCM lecturer, John Tindall, provides a protocol on the use of Reishi (Ganoderma lucidum) in gout. Prof Amin Kamali provides an enzyme analysis of Agaricus blazei biomass which explains how the mushroom supports the immune system.

read more
Download PDF

October'04

In this edition, we address the hepato-protective effect of Cordyceps sinensis in liver damage and how Cordyceps could inhibit hepatic fibro genesis derived from chronic liver injury , retard the development of cirrhosis and notably improve liver function. Dr Celia Santos outlines a study in which Cordyceps sinensis supplementation (3 g per day for 90 day) is provided to fourteen (14) patients with alcoholic fatty livers and the reduction in their liver enzyme levels was compared to a control group who only practiced abstinence. Professor Amin Karmali provides a comparative analysis of those enzymes responsible for detoxification in four mushrooms, Corolus versicolor, Cordyceps sinensis, Ganoderma lucidum (Reishi) and Grifola frondosa (Maitake). Dr Girao Bastos, a leading Portuguese professor in veterinarian medicine, provides three clinical cases on the application of Coriolus versicolor in: Cat with FELV, Dog with abdominal tumor and cat with fibro sarcoma in hip.

read more
Download PDF

April'03


In this seventh edition, we present the results of Dr. Julian Kenyon's 30 patient observational study on the use of Coriolus versicolor supplementation in Stage III and Stage IV cancer patients in which he measures the changes in telomerase activity, interleukin 5, interleukin 12 and Tumor Necrosis Factor Beta over 120 days. In addition two case studies on the use of Coriolus in Ulcerative Colitis and Crohn´s disease are provided. Additionally, a case study on the use of Coriolus versicolor in breast cancer is presented. Finally, Dr. Amin Karmali suggests that the biomass form of mushroom nutrition may be a form of enzyme therapy that could have applications in cancer care.

read more